Browse
We’re here to help

Find guidance on Author Services

Login | Register

Login
Register

Cart Add to Cart

Search
Browse
We’re here to help

Find guidance on Author Services

Home
All Journals
Expert Opinion on Investigational Drugs
List of Issues
Volume 23, Issue 3

Expert Opinion on Investigational Drugs

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

About this journalAbout

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Register a free Taylor & Francis Online account today to boost your research and gain these benefits:

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Register now or learn more

Expert Opinion on Investigational Drugs, Volume 23, Issue 3 (2014)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Investigational Drugs, Volume 23, Issue 3 (2014)

See all volumes and issues

Vol 33, 2024 Vol 32, 2023 Vol 31, 2022 Vol 30, 2021 Vol 29, 2020 Vol 28, 2019 Vol 27, 2018 Vol 26, 2017 Vol 25, 2016 Vol 24, 2015 Volume 23, 2014 Vol 22, 2013 Vol 21, 2012 Vol 20, 2011 Vol 19, 2010 Vol 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Editorial

Histone deacetylases inhibitors: conjugation to other anti-tumour pharmacophores provides novel tools for cancer treatment

Konstantinos A Papavassiliou & Athanasios G Papavassiliou

Pages: 291-294

Published online: 11 Nov 2013

AbstractforHistone deacetylases inhibitors: conjugation to other anti-tumour pharmacophores provides novel tools for cancer treatment | Full Text | References | PDF (142 KB)

815 Views
21 CrossRef citations
0Altmetric

Free Access

Reviews

Review Article

Overview of cyclins D1 function in cancer and the CDK inhibitor landscape: past and present

Mathew C Casimiro, Marco Velasco-Velázquez, Charmina Aguirre-Alvarado & Richard G Pestell MD PhD

Pages: 295-304

Published online: 03 Jan 2014

AbstractforOverview of cyclins D1 function in cancer and the CDK inhibitor landscape: past and present | Full Text | References | PDF (286.1 KB)

1679 Views
133 CrossRef citations
0Altmetric

Review Article

Fibroblast growth factor receptors as therapeutic targets in clear-cell renal cell carcinoma

Guru Sonpavde MD, Christopher D Willey MD PhD & Sunil Sudarshan MD

Pages: 305-315

Published online: 03 Jan 2014

AbstractforFibroblast growth factor receptors as therapeutic targets in clear-cell renal cell carcinoma | Full Text | References | PDF (492.2 KB)

697 Views
17 CrossRef citations
0Altmetric

Review Article

Inula sesquiterpenoids: structural diversity, cytotoxicity and anti-tumor activity

Guo-Wei Wang, Jiang-Jiang Qin, Xiang-Rong Cheng, Yun-Heng Shen, Lei Shan, Hui-Zi Jin & Wei-Dong Zhang

Pages: 317-345

Published online: 03 Jan 2014

AbstractforInula sesquiterpenoids: structural diversity, cytotoxicity and anti-tumor activity | Full Text | References | PDF (2.6 MB)

417 Views
89 CrossRef citations
0Altmetric

Review Article

Roadmap of miR-122-related clinical application from bench to bedside

Zhihua Qiu MD & Yimin Dai MD PhD

Pages: 347-355

Published online: 20 Dec 2013

AbstractforRoadmap of miR-122-related clinical application from bench to bedside | Full Text | References | PDF (247.9 KB)

456 Views
17 CrossRef citations
0Altmetric

Review Article

Non-anticoagulant derivatives of heparin for the management of asthma: distant dream or close reality?

Madhur D Shastri MPharmSc, Gregory M Peterson PhD, Niall Stewart PhD, Sukhwinder Singh Sohal PhD & Rahul P Patel PhD

Pages: 357-373

Published online: 03 Jan 2014

AbstractforNon-anticoagulant derivatives of heparin for the management of asthma: distant dream or close reality? | Full Text | References | PDF (724.2 KB)

232 Views
19 CrossRef citations
0Altmetric

Review Article

Drugs targeting 5-hydroxytryptamine receptors in acute treatments of migraine attacks. A review of new drugs and new administration forms of established drugs

Peer C Tfelt-Hansen MD DMSc, Thomas Pihl MD, Anders Hougaard MD & Dimos D Mitsikostas MD PhD

Pages: 375-385

Published online: 02 Dec 2013

AbstractforDrugs targeting 5-hydroxytryptamine receptors in acute treatments of migraine attacks. A review of new drugs and new administration forms of established drugs | Full Text | References | PDF (462.5 KB)

551 Views
20 CrossRef citations
0Altmetric

Review Article

Dopamine receptor agonists for Parkinson's disease

Fabio Blandini & Marie-Therese Armentero

Pages: 387-410

Published online: 09 Dec 2013

AbstractforDopamine receptor agonists for Parkinson's disease | Full Text | References | PDF (1.3 MB)

826 Views
49 CrossRef citations
0Altmetric

Discontinued Drug Perspective

Article

Discontinued drug projects in the respiratory therapeutic area during 2012

Noel J C Snell FRCP

Pages: 411-415

Published online: 03 Feb 2014

AbstractforDiscontinued drug projects in the respiratory therapeutic area during 2012 | Full Text | References | PDF (152.4 KB)

540 Views
7 CrossRef citations
0Altmetric

Drug Evaluations

WT1 vaccination in acute myeloid leukemia: new methods of implementing adoptive immunotherapy

Lindsay AM Rein MD & Nelson J Chao MD

Pages: 417-426

Published online: 12 Feb 2014

Abstractfor WT1 vaccination in acute myeloid leukemia: new methods of implementing adoptive immunotherapy | Full Text | References | PDF (257.3 KB)

581 Views
11 CrossRef citations
0Altmetric

Embelin – a drug of antiquity: shifting the paradigm towards modern medicine

Radhika Poojari

Pages: 427-444

Published online: 08 Jan 2014

Abstractfor Embelin – a drug of antiquity: shifting the paradigm towards modern medicine | Full Text | References | PDF (770.2 KB)

427 Views
48 CrossRef citations
0Altmetric

Research Article

Article

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Early psoriatic arthritis: clinical and therapeutic challenges.

Francesco Caso et al.

Review Article | Published online: 23 Jul 2024

Developing targeted therapeutics for hepatocellular carcinoma: a critical assessment of promising phase II agents

Elisabeth Amadeo et al.

Review Article | Published online: 22 Jul 2024

Investigational and emerging gastric inhibitory polypeptide (GIP) receptor-based therapies for the treatment of obesity

Robert H. Gaffey et al.

Review Article | Published online: 17 Jul 2024

Safety, tolerability and pharmacokinetics of ASC10, a novel oral double prodrug of a broad-spectrum antiviral agent, β-d-N4-hydroxycytidine: results from a randomized, double-blind, placebo-controlled phase 1 study in Chinese healthy subjects

Jian Liu et al.

Article | Published online: 12 Jul 2024

Open Access

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Investigational Drugs (Vol.23, Iss.3, 2014)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?